pl

Zarejestruj się
Inwestowanie wiąże się z ryzykiem i nie jest odpowiednie dla wszystkich inwestorów.

LLY

802.55

-2.25%↓

UNH

569.62

+1.64%↑

NVO

126.83

-0.63%↓

JNJ

160.55

+0.48%↑

MRK

125.13

-0.6%↓

LLY

802.55

-2.25%↓

UNH

569.62

+1.64%↑

NVO

126.83

-0.63%↓

JNJ

160.55

+0.48%↑

MRK

125.13

-0.6%↓

LLY

802.55

-2.25%↓

UNH

569.62

+1.64%↑

NVO

126.83

-0.63%↓

JNJ

160.55

+0.48%↑

MRK

125.13

-0.6%↓

LLY

802.55

-2.25%↓

UNH

569.62

+1.64%↑

NVO

126.83

-0.63%↓

JNJ

160.55

+0.48%↑

MRK

125.13

-0.6%↓

LLY

802.55

-2.25%↓

UNH

569.62

+1.64%↑

NVO

126.83

-0.63%↓

JNJ

160.55

+0.48%↑

MRK

125.13

-0.6%↓

Strona główna・Stock List・AstraZeneca PLC ADR
Search

AstraZeneca PLC ADR

Closed

78.1 -0.51

Strong Buy

Price update 26 lip 2024, 19:59 UTC

BuySell

Overview

Share price change

24h

Current

Min

78.09

Max

79.45

Recommendations

By TipRanks

Recommendations

Strong Buy

12 Months Forecast

+19.22 upside

Technical Score

By Trading Central

Confidence

Strong Bullish Evidence

77.86 / 78.69 Support & Resistance

AstraZeneca PLC ADR Chart

Related News

25 lip 2024, 09:17 UTC

Earnings

AstraZeneca Raises Guidance After Results Beat Market Expectations -- Update

DJ

Read

25 lip 2024, 06:48 UTC

Earnings

AstraZeneca Raises Guidance After Revenue, Earnings Beat Market Expectations

DJ

Read

12 lip 2024, 19:57 UTC

Major Market Movers

Instil Bio Shares Surge Following Rental Agreement with AstraZeneca

DJ

Read

25 lip 2024, 13:20 UTC

Earnings

AstraZeneca Slides Despite Beating Quarterly Expectations And Hiking Its Outlook -- IBD

DJ

Read

25 lip 2024, 09:21 UTC

Market Talk
Earnings

AstraZeneca's Guidance Lift Is Conservative; Risks to Upside -- Market Talk

DJ

Read

25 lip 2024, 07:05 UTC

Market Talk
Earnings

AstraZeneca Guidance Raise Signals Portfolio Potential -- Market Talk

DJ

Read

25 lip 2024, 06:06 UTC

Earnings

AstraZeneca Increased Interim Dividend by 7c to $1.00

DJ

Read

25 lip 2024, 06:04 UTC

Earnings

AstraZeneca Had Seen Core EPS Grow by Low Double-Digit to Low Teens Percentage Range

DJ

Read

25 lip 2024, 06:04 UTC

Earnings

AstraZeneca Had Seen Total Revenue Grow by Low Double-Digit to Low Teens Percentage Range

DJ

Read

25 lip 2024, 06:04 UTC

Earnings

AstraZeneca Sees Core EPS Growth in 2024 by Mid Teens Percentage Range At Constant Currency

DJ

Read

25 lip 2024, 06:04 UTC

Earnings

AstraZeneca Sees Total Revenue Growth in 2024 by Mid Teens Percentage Range At Constant Currency

DJ

Read

25 lip 2024, 06:03 UTC

Earnings

AstraZeneca Raises 2024 View

DJ

Read

25 lip 2024, 06:02 UTC

Earnings

AstraZeneca 2Q Revenue Consensus Was $12.7B

DJ

Read

25 lip 2024, 06:02 UTC

Earnings

AstraZeneca 2Q Core EPS Consensus Was $1.95

DJ

Read

25 lip 2024, 06:00 UTC

Earnings

AstraZeneca PLC 2Q Adj EPS $1.98

DJ

Read

25 lip 2024, 06:00 UTC

Earnings

AstraZeneca PLC 2Q Pretax Pft $2.4B

DJ

Read

25 lip 2024, 06:00 UTC

Earnings

AstraZeneca PLC 2Q Rev $12.94B

DJ

Read

25 lip 2024, 06:00 UTC

Earnings

AstraZeneca PLC 2Q Oper Pft $2.75B

DJ

Read

25 lip 2024, 06:00 UTC

Earnings

AstraZeneca PLC 2Q Net Pft $1.93B

DJ

Read

25 lip 2024, 06:00 UTC

Earnings

AstraZeneca PLC 2Q EPS $1.24

DJ

Read

15 lip 2024, 06:04 UTC

Acquisitions, Mergers, Takeovers

AstraZeneca: Amolyt Pharma's Hldrs Eligible to Receive $250M On Achieving Specific Milestone

DJ

Read

15 lip 2024, 06:04 UTC

Acquisitions, Mergers, Takeovers

AstraZeneca: Amolyt Pharma's Hldrs Eligible to Receive $250M On Achieving Specific Milestone

DJ

Read

15 lip 2024, 06:02 UTC

Acquisitions, Mergers, Takeovers

AstraZeneca: Acquisition Includes $800M Upfront at Deal Closing

DJ

Read

15 lip 2024, 06:02 UTC

Acquisitions, Mergers, Takeovers

AstraZeneca: Amolyt Pharma's Total Consideration of Up to $1.05B

DJ

Read

15 lip 2024, 06:01 UTC

Acquisitions, Mergers, Takeovers

AstraZeneca: Acquisition Bolsters Alexion Rare Disease Late-Stage Pipeline

DJ

Read

15 lip 2024, 06:00 UTC

Acquisitions, Mergers, Takeovers

AstraZeneca Completes Acquisition of Amolyt Pharma

DJ

Read

15 lip 2024, 06:00 UTC

Acquisitions, Mergers, Takeovers

AstraZeneca PLC Acquisition of Amolyt Pharma completed

DJ

Read

15 lip 2024, 06:00 UTC

Acquisitions, Mergers, Takeovers

AstraZeneca PLC Acquisition of Amolyt Pharma completed

DJ

Read

20 cze 2024, 20:16 UTC

Top News

Why Wall Street Is Chasing Ozempic Wannabes -- Heard on the Street -- Update

DJ

Read

20 cze 2024, 18:09 UTC

Top News

Why Wall Street Is Chasing Ozempic Wannabes -- Heard on the Street -- Update

DJ

Read

Peer Comparison

Price change

AstraZeneca PLC ADR Forecast

Price Target

By TipRanks

19.22% upside

12 Months Forecast

Average 93.61 USD  19.22%

High 136 USD

Low 74 USD

Based on 8 Wall Street analysts offering 12 month price targets forAstraZeneca PLC ADR - Dist in the last 3 months.

Rating Consensus

By TipRanks

Strong Buy

8 ratings

7

Buy

1

Hold

0

Sell

Based on 8 analysts giving stock ratings to AstraZeneca PLC ADR - Dist in the past 3 months.

Technical Score

By Trading Central

77.86 / 78.69Support & Resistance

Short Term

Strong Bullish Evidence

Recent bullish events outweigh bearish events.

Intermediate Term

Neutral Evidence

The bullish and bearish events are balanced.

Long Term

Weak Bullish Evidence

There is one bullish event.

Other stocks from the sector

LLY

Eli Lilly and Co.

802.55

↓-2.25%

UNH

UnitedHealth Group Inc

569.62

↑ +1.64%

NVO

Novo Nordisk A-S

126.83

↓-0.63%

JNJ

Johnson and Johnson

160.55

↑ +0.48%

MRK

Merck & Co Inc.

125.13

↓-0.6%